AI Bias Analysis
4 models · Takes ~15 seconds
A targeted drug from Enliven Therapeutics induced molecular responses in nearly half of patients with advanced leukemia, new data show.
Source
Stat News
Opens original article in a new tab
Major Medicare Advantage plans almost always reversed their denials on appeal, raising big questions about barriers to care.
Seniors' drug costs rise sharply, Enliven's leukemia drugs, and more biotech news from The Readout
(MedPage Today) -- Note that some links may require registration or subscription. Health officials sounded the alarm on the presence of tularemia, or "rabbit fever," in northern Colorado. (USA Today via Yahoo!) The number of confirmed...
More employers are planning to drop coverage of GLP-1 drugs for weight loss next year as increasing numbers of people take the medications
